INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Every figure this model derived for IART, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 59,525,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 274,084,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 1,191,482,000 AssetsCurrent 2026-06-30
current liabilities 330,881,000 LiabilitiesCurrent 2026-06-30
equity 1,043,377,000 StockholdersEquity 2026-06-30
interest expense 91,857,000 InterestExpenseNonoperating 2026-06-30
ocf 85,327,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 1,647,666,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 22,427,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up IART on one particular measure came for.

RatioValue
cash operating margin8.06
current ratio3.73
current ratio reported3.6
deferred revenue growth5.37
dilution pct-0.44
ebit cagr-30.92
fcf margin1.57
growth cv1.28
interest cover0.71
net debt ebitda3.92
operating margin3.98
owner earnings margin0.2
revenue growth1.6
revenue growth per share2.05
roic3.51
rule of 405.58
sbc pct revenue1.36

What to be careful about

What this model itself distrusts about IART's figures. Written by the derivation as it ran, not added afterwards.